Cti Biopharma reported $114K in Ordinary Share Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Applied Genetic Technologies AGTC:US $ 0.05M 0M
Baxter International BAX:US $ 683M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cti Biopharma CTIC:US $ 0.11M 0.01M
Cytori Therapeutics CYTX:US $ 0.02M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Geron GERN:US $ 0.38M 0.05M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Northwest Biotherapeutics NWBO:US 1.03M 64K
Novartis NOVN:VX SF 890M 11M
Novartis NVS:US $ 890M 11M
Seattle Genetics SGEN:US $ 0.18M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
YTE INCY:US $ 0.22M 0M